News and Media

Gene S Updates

Innovator of the Year 2025

We’re thrilled to announce that Gene S was named a finalist for the 2025 Western Australian Innovator of the Year Awards — in the Wesfarmers Wellbeing Platinum Award category.

This award celebrates WA innovators who have developed outstanding products, technologies, processes, or services that advance social or medical wellbeing in the community — and we’re honoured to be recognised for our contribution to precision health care.

Our first product, RosaMind, is a breakthrough in personalised mental health care — and we’re incredibly grateful to be acknowledged alongside WA’s leading innovators in health and wellbeing.

Gene S in the Media

We are honoured to be featured on Channel 7 News, where our platform RosaMind was described as a “game changer for the health industry”, bringing “life-changing hope for patients.” 

This feature highlighted how our simple test can be utilised to match a patient’s mental diagnosis with their most effective prescription, using DNA to eliminate the trial-and-error approach to medication management, and helping patients find the best mental health treatment faster. 

Our feature on ABC News was an exciting opportunity to showcase the vision behind Gene S and our journey as a start-up, as well as highlight how our first product, RosaMind, empowers clinicians to prescribe the right medication based on each patient’s unique genetic profile. 

Research & Publications

Gene S contributes to the advancement of pharmacogenomics through peer-reviewed research and collaboration. Our recent publications reflect our commitment to driving innovation in precision medicine. 

PharmacoGENEtics in Youth Depression (GENE-YD) Study Protocol:

This pilot randomised controlled trial investiges the feasibility and acceptability of pharmacogenomic-guided antidepressant prescribing in adolescents and young adults. The findings aim to inform the design of a future trial assessing personalised prescribing treatment outcomes in youths.

Real-World Application of Pharmacogenomics in Paediatrics

This review explores the role of pharmacogenomic testing in paediatrics, specifically in oncology, psychiatry and other key therapeutic areas. It highlights how genotype-guided prescribing can improve treatment safety and efficacy to support more personalised prescribing for children.

Our Location

1st Fl, M Block, QEII Medical Centre, Nedlands 6009 WA

PO Box 4056, Woodlands WA 6018

Get in touch with Gene S